Amphinex
Amphinex is a photosensitising agent used in photodynamic therapy for treating superficial cancers.
It has had promising preliminary results in early trials on patients with advanced head and neck cancer{{cite web|url=http://www.pcibiotech.no/content/successful-completion-third-dose-group-amphinex-study-continued-good-tolerability-and-strong |title=Successful completion of the third dose group in the Amphinex study. Continued good tolerability and strong tumour response is reported, with an apparent high treatment specificity for cancer cells. | PCI Biotech |accessdate=2010-04-06 |url-status=dead |archiveurl=https://web.archive.org/web/20110724182421/http://www.pcibiotech.no/content/successful-completion-third-dose-group-amphinex-study-continued-good-tolerability-and-strong |archivedate=2011-07-24 }} Successful completion of the third dose group in the Amphinex study. March 2010
"Inoperable cancers killed by new laser surgery" The Times. UK. 3-April-2010 p15